Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Bruxelles  >  Solvay    SOLB   BE0003470755

SOLVAY

(SOLB)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Solvay :'s Udel PSU helps Nordson MEDICAL develop new aseptic disconnects

share with twitter share with LinkedIn share with facebook
share via e-mail
0
09/12/2019 | 09:28am EDT

Solvay's Udel PSU enabled Nordson MEDICAL to develop its Spaulding Series Aseptic Disconnects for pharmaceutical and bioprocessing.

Udel P-1700 polysulfone (PSU) was chosen for the new series of bioprocess fittings due to its biocompatibility, transparency, strength and rigidity, broad temperature range and compatibility with gamma radiation (up to 50 kGy) and steam sterilization. These innovative connectors are on display in Solvay's booth (#1114) at BioProcess International 2019 being held at the Boston Convention and Exhibition Center (BCEC) in Boston, Mass.

Udel P-1700 PSU readily withstands the required operating temperature range of -40-degreeC to 138-degreeC (-40-degreeF to 280-degreeF), enabling the aseptic disconnects to be used in cryogenic conditions and be steam sterilized. The material's transparency allows processors to observe the flow of liquid through the connectors, and its combination of high heat resistance and hydrolytic stability provide an important advantage over polycarbonate (PC), which is highly susceptible to stress cracking. Udel P-1700 PSU is animal-derived component free (ADCF), and it meets USP Class IV requirements for biocompatibility. In addition, components can be molded to tight tolerances with minimal flash and scrap.

'Adopting Solvay's high-performance Udel PSU meant a significant shift from the polyolefins we've historically used,' said Ken Davis, global product line manager for biopharmaceuticals at Nordson MEDICAL. 'Solvay's technical support and processing guidance made the transition to this new material smooth and easy. It's performing beautifully and we look forward to future collaborations with Solvay on other products.'

The Spaulding Series Aseptic Disconnects provide a leak-free connection, eliminating the need for pinch clamps and tube welders. Smooth disconnects are achievable with the easy-to-use design, and valuable fluids are protected by valves that automatically shut off flow when the fittings are disconnected. Validation and test results confirm their suitability in pre- and post-sterilized systems. The connectors are well suited for processing biopharmaceuticals, vaccines and active pharmaceutical ingredients.

'Solvay is committed to supplying next-generation polymers to support advancements in bioprocessing, cell and gene therapies and pharmaceutical processing,' said Eva Heintz, global marketing manager for Healthcare at Solvay's Specialty Polymers global business unit. 'By serving as a true partner to companies like Nordson MEDICAL, Solvay helps to match key material attributes to specific application requirements.'

Solvay offers a broad selection of high-purity, specialty polymers for pharmaceutical and bioprocessing technologies. Products include Udel PSU, Veradel HC polyethersulfone (PESU), Radel polyphenylsulfone (PPSU), Ixef polyarylamide (PARA), KetaSpire polyetheretherketone (PEEK) and AvaSpire polyaryletherketone (PAEK). Typical applications include filtration media and housings, components and instruments, as well as fluid and storage management.

Contact:

Tel: +1 770 772 8451

(C) 2019 Electronic News Publishing, source ENP Newswire

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on SOLVAY
10/18UCORE RARE METALS : Updates on M-3 Plan of Action & RO Funding Participation
AQ
10/17GLOBAL MARKETS LIVE : Nestlé, Netflix, Huawei, General Motors…
10/17SOLVAY : to raise Tecnoflon® fluoroelastomer FKM capacity in Italy by 30% to mee..
AQ
10/17Solvay to raise Tecnoflon® fluoroelastomer FKM capacity in Italy by 30% to me..
GL
10/15SOLVAY : licenses MediTECH to fulfill orders for Zeniva PEEK shapes
AQ
09/24GLOBAL MARKETS LIVE : Samsung, Apple, AB InBev, Google, Facebook…
09/24Participation Notification by Blackrock Inc.
GL
09/24Solvay increases its soda ash and bicarbonate production capacity to address ..
GL
09/24SOLVAY : Threshold crossings
CO
09/23Solvay expands its aerospace thermoplastic composites capacity in the US to m..
GL
More news
Financials (EUR)
Sales 2019 10 555 M
EBIT 2019 1 509 M
Net income 2019 809 M
Debt 2019 3 526 M
Yield 2019 3,88%
P/E ratio 2019 12,4x
P/E ratio 2020 12,5x
EV / Sales2019 1,28x
EV / Sales2020 1,19x
Capitalization 9 940 M
Chart SOLVAY
Duration : Period :
Solvay Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SOLVAY
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Average target price 106,98  €
Last Close Price 96,36  €
Spread / Highest target 45,3%
Spread / Average Target 11,0%
Spread / Lowest Target -7,64%
EPS Revisions
Managers
NameTitle
Ilham Kadri Chief Executive Officer & Director
Nicolas Jacques Boël Chairman
Karim Hajjar Chief Financial Officer
Philippe Warny Head-Research, Development & Technology
Jean-Marie Ernest Solvay Non-Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
SOLVAY10.35%11 073
SAUDI BASIC INDUSTRIES CORPORATION SJSC--.--%72 382
AIR LIQUIDE19.18%61 680
LYONDELLBASELL INDUSTRIES N.V.3.55%28 868
WANHUA CHEMICAL GROUP55.23%19 176
NAN YA PLASTICS CORP--.--%18 428